Why the study?
Recent advances in biomedical imaging enable noninvasive physiological, cellular, and molecular imaging in small animal models of cardiovascular disease with translational relevance to humans.
This review highlights the advancements and applications of noninvasive biomedical imaging techniques, such as ultrasound, PET, and MRI, in small animal models of cardiovascular disease.
Reviews multimodal imaging in small animal CVD models; leaves open standardization and clinical translation.
Major advances in biomedical imaging have occurred over the last 2 decades and now allow many physiological, cellular, and molecular processes to be imaged noninvasively in small animal models of cardiovascular disease. Many of these techniques can be also used in humans, providing pathophysiological context and helping to define the clinical relevance of the model. Ultrasound remains the most widely used approach, and dedicated high-frequency systems can obtain extremely detailed images in mice. Likewise, dedicated small animal tomographic systems have been developed for magnetic resonance, positron emission tomography, fluorescence imaging, and computed tomography in mice. In this article, we review the use of ultrasound and positron emission tomography in small animal models, as well as emerging contrast mechanisms in magnetic resonance such as diffusion tensor imaging, hyperpolarized magnetic resonance, chemical exchange saturation transfer imaging, magnetic resonance elastography and strain, arterial spin labeling, and molecular imaging.
No takes yet. Share an insight, caveat, or question.
Sosnovik et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: